Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1991 Oct;139(4):731–736.

Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment.

T Nakamura 1, I Ebihara 1, Y Tomino 1, K Okumura 1, H Koide 1
PMCID: PMC1886315  PMID: 1928297

Abstract

Perforin is one of the important cytolytic factors in cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. In this study, the authors examined perforin mRNA levels in the kidney, spleen, liver, lung, heart, and brain of NZB/W F1 lupus mice and NZW mice. Perforin mRNA levels in the kidney, spleen, liver, and lung of NZB/W F1 mice increased significantly with age, whereas those in the heart and brain of NZB/W F1 mice showed little change between 2 and 10 months of age. In all tissues examined in NZW, control mice perforin mRNA levels showed little change during the experimental period. In addition, the authors examined the effect of methylprednisolone (MPSL) on perforin gene expression in the tissues of NZB/W F1 mice. MPSL ameliorated the increase in perforin mRNA levels in the kidney, spleen, liver, and lung of NZB/W F1 mice. These findings suggest that perforin may contribute to tissue injuries in autoimmune lupus mice and that MPSL may be effective in lupus partly by decreasing perforin expression.

Full text

PDF
731

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando D. G., Sercarz E. E., Hahn B. H. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol. 1987 May 15;138(10):3185–3190. [PubMed] [Google Scholar]
  2. Caligaris-Cappio F., Bergui L., Tesio L., Ziano R., Camussi G. HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus. Clin Exp Immunol. 1985 Jan;59(1):185–189. [PMC free article] [PubMed] [Google Scholar]
  3. Cavallo T., Graves K., Granholm N. A. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants. Lab Invest. 1983 Oct;49(4):476–481. [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleveland D. W., Lopata M. A., MacDonald R. J., Cowan N. J., Rutter W. J., Kirschner M. W. Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell. 1980 May;20(1):95–105. doi: 10.1016/0092-8674(80)90238-x. [DOI] [PubMed] [Google Scholar]
  7. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  8. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  9. Joag S. V., Liu C. C., Kwon B. S., Clark W. R., Young J. D. Expression of mRNAs for pore-forming protein and two serine esterases in murine primary and cloned effector lymphocytes. J Cell Biochem. 1990 May;43(1):81–88. doi: 10.1002/jcb.240430108. [DOI] [PubMed] [Google Scholar]
  10. Kawasaki A., Shinkai Y., Kuwana Y., Furuya A., Iigo Y., Hanai N., Itoh S., Yagita H., Okumura K. Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. Int Immunol. 1990;2(7):677–684. doi: 10.1093/intimm/2.7.677. [DOI] [PubMed] [Google Scholar]
  11. Lee K. C., Langman R. E., Paetkau V. H., Diener E. The cellular basis of cortisone-induced immunosuppression of the antibody response studied by its reversal in vitro. Cell Immunol. 1975 Jun;17(2):405–417. doi: 10.1016/s0008-8749(75)80044-x. [DOI] [PubMed] [Google Scholar]
  12. Levine M. A., Claman H. N. Bone marrow and spleen: dissociation of immunologic properties by cortisone. Science. 1970 Mar 13;167(3924):1515–1517. doi: 10.1126/science.167.3924.1515. [DOI] [PubMed] [Google Scholar]
  13. Lichtenheld M. G., Olsen K. J., Lu P., Lowrey D. M., Hameed A., Hengartner H., Podack E. R. Structure and function of human perforin. Nature. 1988 Sep 29;335(6189):448–451. doi: 10.1038/335448a0. [DOI] [PubMed] [Google Scholar]
  14. Liu C. C., Joag S. V., Kwon B. S., Young J. D. Induction of perforin and serine esterases in a murine cytotoxic T lymphocyte clone. J Immunol. 1990 Feb 15;144(4):1196–1201. [PubMed] [Google Scholar]
  15. Liu C. C., Rafii S., Granelli-Piperno A., Trapani J. A., Young J. D. Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med. 1989 Dec 1;170(6):2105–2118. doi: 10.1084/jem.170.6.2105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lowrey D. M., Aebischer T., Olsen K., Lichtenheld M., Rupp F., Hengartner H., Podack E. R. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci U S A. 1989 Jan;86(1):247–251. doi: 10.1073/pnas.86.1.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Morimoto C., Reinherz E. L., Schlossman S. F., Schur P. H., Mills J. A., Steinberg A. D. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest. 1980 Nov;66(5):1171–1174. doi: 10.1172/JCI109948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Müller C., Kägi D., Aebischer T., Odermatt B., Held W., Podack E. R., Zinkernagel R. M., Hengartner H. Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol. 1989 Jul;19(7):1253–1259. doi: 10.1002/eji.1830190716. [DOI] [PubMed] [Google Scholar]
  19. Nagler-Anderson C., Lichtenheld M., Eisen H. N., Podack E. R. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes. J Immunol. 1989 Dec 1;143(11):3440–3443. [PubMed] [Google Scholar]
  20. Oshimi K., Shinkai Y., Okumura K., Oshimi Y., Mizoguchi H. Perforin gene expression in granular lymphocyte proliferative disorders. Blood. 1990 Feb 1;75(3):704–708. [PubMed] [Google Scholar]
  21. Shinkai Y., Takio K., Okumura K. Homology of perforin to the ninth component of complement (C9). Nature. 1988 Aug 11;334(6182):525–527. doi: 10.1038/334525a0. [DOI] [PubMed] [Google Scholar]
  22. Shinkai Y., Yoshida M. C., Maeda K., Kobata T., Maruyama K., Yodoi J., Yagita H., Okumura K. Molecular cloning and chromosomal assignment of a human perforin (PFP) gene. Immunogenetics. 1989;30(6):452–457. doi: 10.1007/BF02421177. [DOI] [PubMed] [Google Scholar]
  23. Smyth M. J., Ortaldo J. R., Bere W., Yagita H., Okumura K., Young H. A. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol. 1990 Aug 15;145(4):1159–1166. [PubMed] [Google Scholar]
  24. Smyth M. J., Ortaldo J. R., Shinkai Y., Yagita H., Nakata M., Okumura K., Young H. A. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. J Exp Med. 1990 Apr 1;171(4):1269–1281. doi: 10.1084/jem.171.4.1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Young L. H., Foster C. S., Young J. D. In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I. Am J Pathol. 1990 May;136(5):1021–1030. [PMC free article] [PubMed] [Google Scholar]
  26. Young L. H., Klavinskis L. S., Oldstone M. B., Young J. D. In vivo expression of perforin by CD8+ lymphocytes during an acute viral infection. J Exp Med. 1989 Jun 1;169(6):2159–2171. doi: 10.1084/jem.169.6.2159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Young L. H., Peterson L. B., Wicker L. S., Persechini P. M., Young J. D. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J Immunol. 1989 Dec 15;143(12):3994–3999. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES